Form 4 for DCOY Decoy Therapeutics Inc.
Accepted 2022-05-05 00:00:00 ET · period of report 2022-05-03 · accession 0001615219-22-000067 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-05 | 2022-05-03 | DCOY | Rosenblum Mark J | CFO, EVP Fin | A - Grant | $0.19 | +10.0K | 120.3K | +9% | +$1,900 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-03 | A | A | 10,000 | $0.19 | 120,319 | D | — | — |